GO2 for Lung Cancer relentlessly confronts lung cancer on every front, every day, for everyone. Founded by patients and survivors, we are dedicated to increasing survival and quality of life for those at risk, diagnosed, and living with lung cancer.
Don’t miss our next Lung Cancer Living Room tomorrow, March 17th, at 5:30pm PT - streaming LIVE here on our YouTube channel - as we talk all about CLINICAL TRIALS. Hear our special guest, Dr. Jorge Nieva of USC Norris Cancer Center, share what he’ll be discussing with GO2 Chief Patient Officer, Danielle Hicks.
Our newest Living Room® Short talks about how a new small cell lung cancer medication was derived from the sea squirt (youtube.com/shorts/kPLx_qCCLB8). But it's not the only lung cancer treatment derived from nature. Which of the following widely used lung cancer chemotherapy drugs was originally discovered in the bark of the Pacific yew tree?
Empower yourself with knowledge! 🧠💙 Navigating a non-small cell lung cancer (NSCLC) diagnosis can feel overwhelming, but education is key to experiencing better outcomes and a better quality of life.
In our latest Lung Cancer Living Room episode, Dr. Eric Singhi (@lungoncdoc on IG) breaks down complex topics into plain language, covering the latest treatments, the vital importance of comprehensive biomarker testing , and how to talk to your doctor about second opinions.
As Dr. Singhi beautifully states: being an empowered patient doesn't mean you have to know everything—it just means you feel included in your cancer care.
Watch the full episode to learn how to ask the right questions, understand your options, and confidently advocate for your best care! 👇
Pop Quiz! 🎣 In our latest video, Dr. Josh Sabari compares getting a liquid biopsy to fishing. According to his analogy, what does it mean if your liquid biopsy comes back negative (non-diagnostic)?
Have you or someone you know ever had lung cancer screening? While 16 million people in the US currently qualify for the screening, only a small fraction of that number are getting it. If you've had lung cancer screening, share your experience in the comments!
Pop Quiz! 🧠💙 In our newest Living Room® Highlight out today, Oncology Social Worker and survivor Alison Sachs opens up about "scanxiety" and the big, difficult emotions that come with a lung cancer diagnosis. To help patients build a practical toolkit for managing these moments, GO2’s new "Mind Over Matter" (MOM) program teaches evidence-based coping skills.
Which science-backed psychological approach does the program use?
Don't miss your chance to ask a question! This coming Tuesday at 5:30pm PT, our Lung Cancer Living Room® patient education and empowerment program will livestream it's next in-person episode with professor and medical oncologist, Dr. Eric Singhi from Univ. of Texas MD Anderson Cancer Center. Watch live and join the conversation - ask a question to Dr. Singhi in real time! He'll be discussing non-small cell lung cancer navigation - including treatments and biomarkers. You won't want to miss it! Please subscribe to our channel to get a reminder notification! And please RSVP to let us know you’ll join us, whether in person or virtually: events.go2.org/2026FebruaryLivingRoom
In October of last year, our Lung Cancer Living Room® partnered with the Young Lung Cancer Initiative (📸@younglungcancer) and spoke with four young adults with lung cancer about the unique realities of facing this diagnosis at a younger age. Today we shared a moment from that episode with co-founder of YLCI, Leah Phillips, who shares a perspective from her oncologist and a reminder of how fast the treatment landscape is changing for the lung cancer community. To watch the full Living Room® episode with the YLCI, go to: https://youtu.be/Buuq0eYrGvU
Want to check your answer to yesterday's quiz on the relationship between genomic mutations and the likely effectiveness of immunotherapy? Jump to the 5 minute mark in yesterday's new Living Room® Highlight video with Dr. Sabari.
Pop quiz! We are releasing an INFO-PACKED new highlight video into the CheckMate 816 trial that ushered in a new standard of care for early-stage patients: immunotherapy before surgery. Dr. Sabari explains that the study shows that patients that are low expressors or non-expressors of PD-L1 still showed benefit from immunotherapy. Nevertheless, comprehensive biomarker testing in advance is essential to determine if immunotherapy is the right strategy for you.
QUESTION: Why is it essential to get biomarker testing and find out if you have genomic mutations like EGFR, ALK, ROS1, NTRK, etc. before getting immunotherapy?
GO2 for Lung Cancer
Don’t miss our next Lung Cancer Living Room tomorrow, March 17th, at 5:30pm PT - streaming LIVE here on our YouTube channel - as we talk all about CLINICAL TRIALS. Hear our special guest, Dr. Jorge Nieva of USC Norris Cancer Center, share what he’ll be discussing with GO2 Chief Patient Officer, Danielle Hicks.
March 17th is All About Clinical Trials #lungcancer #live
youtube.com/shorts/YQiFOHbw1_...
1 day ago | [YT] | 0
View 0 replies
GO2 for Lung Cancer
Our newest Living Room® Short talks about how a new small cell lung cancer medication was derived from the sea squirt (youtube.com/shorts/kPLx_qCCLB8). But it's not the only lung cancer treatment derived from nature. Which of the following widely used lung cancer chemotherapy drugs was originally discovered in the bark of the Pacific yew tree?
4 days ago | [YT] | 2
View 0 replies
GO2 for Lung Cancer
Empower yourself with knowledge! 🧠💙
Navigating a non-small cell lung cancer (NSCLC) diagnosis can feel overwhelming, but education is key to experiencing better outcomes and a better quality of life.
In our latest Lung Cancer Living Room episode, Dr. Eric Singhi (@lungoncdoc on IG) breaks down complex topics into plain language, covering the latest treatments, the vital importance of comprehensive biomarker testing , and how to talk to your doctor about second opinions.
As Dr. Singhi beautifully states: being an empowered patient doesn't mean you have to know everything—it just means you feel included in your cancer care.
Watch the full episode to learn how to ask the right questions, understand your options, and confidently advocate for your best care! 👇
1 week ago | [YT] | 4
View 0 replies
GO2 for Lung Cancer
Pop Quiz! 🎣 In our latest video, Dr. Josh Sabari compares getting a liquid biopsy to fishing. According to his analogy, what does it mean if your liquid biopsy comes back negative (non-diagnostic)?
(Watch the new short Living Room® Highlight video if you want to find out! 😉 www.youtube.com/shorts/bu5Yin...)
2 weeks ago | [YT] | 0
View 0 replies
GO2 for Lung Cancer
Have you or someone you know ever had lung cancer screening? While 16 million people in the US currently qualify for the screening, only a small fraction of that number are getting it. If you've had lung cancer screening, share your experience in the comments!
3 weeks ago | [YT] | 0
View 0 replies
GO2 for Lung Cancer
Pop Quiz! 🧠💙 In our newest Living Room® Highlight out today, Oncology Social Worker and survivor Alison Sachs opens up about "scanxiety" and the big, difficult emotions that come with a lung cancer diagnosis. To help patients build a practical toolkit for managing these moments, GO2’s new "Mind Over Matter" (MOM) program teaches evidence-based coping skills.
Which science-backed psychological approach does the program use?
3 weeks ago | [YT] | 0
View 0 replies
GO2 for Lung Cancer
Don't miss your chance to ask a question! This coming Tuesday at 5:30pm PT, our Lung Cancer Living Room® patient education and empowerment program will livestream it's next in-person episode with professor and medical oncologist, Dr. Eric Singhi from Univ. of Texas MD Anderson Cancer Center. Watch live and join the conversation - ask a question to Dr. Singhi in real time! He'll be discussing non-small cell lung cancer navigation - including treatments and biomarkers. You won't want to miss it! Please subscribe to our channel to get a reminder notification! And please RSVP to let us know you’ll join us, whether in person or virtually: events.go2.org/2026FebruaryLivingRoom
4 weeks ago | [YT] | 1
View 1 reply
GO2 for Lung Cancer
In October of last year, our Lung Cancer Living Room® partnered with the Young Lung Cancer Initiative (📸@younglungcancer) and spoke with four young adults with lung cancer about the unique realities of facing this diagnosis at a younger age. Today we shared a moment from that episode with co-founder of YLCI, Leah Phillips, who shares a perspective from her oncologist and a reminder of how fast the treatment landscape is changing for the lung cancer community.
To watch the full Living Room® episode with the YLCI, go to: https://youtu.be/Buuq0eYrGvU
4 weeks ago | [YT] | 1
View 0 replies
GO2 for Lung Cancer
Want to check your answer to yesterday's quiz on the relationship between genomic mutations and the likely effectiveness of immunotherapy? Jump to the 5 minute mark in yesterday's new Living Room® Highlight video with Dr. Sabari.
4 weeks ago (edited) | [YT] | 2
View 0 replies
GO2 for Lung Cancer
Pop quiz! We are releasing an INFO-PACKED new highlight video into the CheckMate 816 trial that ushered in a new standard of care for early-stage patients: immunotherapy before surgery. Dr. Sabari explains that the study shows that patients that are low expressors or non-expressors of PD-L1 still showed benefit from immunotherapy. Nevertheless, comprehensive biomarker testing in advance is essential to determine if immunotherapy is the right strategy for you.
QUESTION: Why is it essential to get biomarker testing and find out if you have genomic mutations like EGFR, ALK, ROS1, NTRK, etc. before getting immunotherapy?
4 weeks ago | [YT] | 1
View 0 replies
Load more